Rama Ranganathan is the main inventor of sequence-based computational algorithms for molecular design, the developer of cutting-edge methods for rapid, cost-efficient, automated gene synthesis, and the scientist that helped start the rapidly growing technologies for deep-sequencing coupled high-throughput biochemical assays. He is responsible for defining and establishing scientific direction, strategy and implementation for Evozyne. In addition, Dr. Ranganathan is a Joseph Regenstein Professor in the Department of Biochemistry and Molecular Biology, Pritzker School of Molecular Engineering, and the College at the University of Chicago. He holds an MD and PhD in neuroscience from UC San Diego.

Andrew Ferguson is responsible for leading the computational, machine learning, and software development efforts at Evozyne. Andrew is an Associate Professor at the Pritzker School of Molecular Engineering at the University of Chicago. His research uses theory, simulation, and machine learning to understand and design self-assembling materials, macromolecular folding, and antiviral therapies. He holds a PhD in chemical and biological engineering from Princeton University, and was a Postdoctoral Fellow of the Ragon Institute of MGH, MIT, and Harvard.